Read + Share
Amedeo Smart
Independent Medical Education
Zaza A, Zardo G, Banella C, Tucci S, et al. PML::RARalpha+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias. Leukemia 2025;39:2708-2720.PMID: 40931045
Email
LinkedIn
Privacy Policy